Secondary Offerings

Secondaries announced 10.5.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Idera Pharmaceuticals Symbol: IDRA Price: Last trade $2.61 Trade Date: 10/7 Shares: 19.2 million Underwriter(s)J.P. Morgan, Goldman Sachs Rating=Subscription Needed

Secondaries announced 10.4.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Advanced Accelerator Applications S.A. Symbol: AAAP Price: Last trade $37.40 Trade Date: 10/6 Shares: 3.34 million Underwriter(s) J.P. Morgan, Jefferies, Wells[…]

Secondaries announced 9.29.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: VolitionRX Symbol: VNRX Price: Last trade $5.58 Description: No re-offer available Trade Date: 9/30 Shares: 1.8 million Underwriter(s)National Securities Corporation Rating=Subscription[…]

Secondaries announced 9.27.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Independence Realty Trust Symbol: IRT Price: Last trade $10.61 Trade Date: 9/30 Shares: 25 million Underwriter(s)Citigroup Rating=Subscription Needed Company: Foamix Pharmaceuticals[…]

Secondaries announced 9.21.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Sarepta Therapeutics, Inc. Symbol: SRPT Price: Last trade $56.09 Trade Date: 9/23 Shares: 4 million Underwriter(s) J.P. Morgan, Goldman Sachs, Credit[…]

Secondaries announced 9.20.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: CareDx Symbol: CDNA Price: Last trade $4.30 Description: No re-offer available Trade Date: 9/21 Shares: 2.3 million Underwriter(s) Piper Jaffray Rating=Subscription[…]

Secondaries announced 9.19.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Aquinox Symbol: AQXP Price: Last trade $12.68 Description: No re-offer range available Trade Date: 9/20 Shares: 4.73 million Underwriter(s) Leerink Partners,[…]

Secondaries announced 9.15.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Platform Specialty Products Corporation Symbol: PAH Price: Last trade $8.96 Trade Date: 9/16 Shares: 39 million Underwriter(s) Credit Suisse, UBS Rating=Subscription[…]

Secondaries announced 9.14.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Star Bulk Carriers Symbol: SBLK Price: Last trade $4.68 Description: Re-offer $4.30-$4.55 Trade Date: 9/15 Shares: 11 million Underwriter(s) Citigroup, Clarksons[…]

Secondaries announced 09-13.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Callidus Software Inc. Symbol: CALD Price: Last trade $18.91 Trade Date: 9/16 Shares: 4 million Underwriter(s) Piper Jaffray, Credit Suisse Co[…]

Secondaries announced 9.12.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: VimpelCom Ltd. Symbol: VIP Price: Last trade $3.90 Trade Date: 9/16 Shares: 142.5 million ADSs Underwriter(s) Morgan Stanley, J.P. Morgan, Citigroup,[…]

Secondaries announced 9.8.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: IMPAC Mortgage Symbol: IMH Price: Last trade $16.87 Trade Date: TBD Shares: 2.5 million Underwriter(s) JMP Securities Rating=Subscription Needed Company: CoLucid[…]

Secondaries announced 9.7.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Sage Therapeutics, Inc. Symbol: SAGE Price: Last trade $41.34 Trade Date: 9/9 Shares: 3.63 million Underwriter(s) J.P. Morgan, Goldman Sachs Co[…]

Secondaries announced 9.6.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Proteostasis Therapeutics Symbol: PTI Price: Last trade $15.24 Trade Date: 9/9 Shares: 4.25 million Underwriter(s)Leerink Partners, RBC Capital Markets, H.C. Wainwright[…]

Secondaries announced 8.31.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Communications Sales & Leasing, Inc.-BLOCK Symbol: CSAL Price: Last Trade $31.20 Description: Re-offer Range: $30.00-$30.50 Trade Date: 9/1 Shares: 544,000 Underwriter(s)[…]

Secondaries announced 8.30.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Atossa Genetics Symbol: ATOS Price: Last trade $3.46 Description: No re-offer range available Trade Date: 8/31 Shares: TBD Underwriter(s) Aegis Capital[…]

Secondaries announced 8.23.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: CommScope Holding Company Symbol: COMM Price: Last trade $29.19 Description: Re-offer $29.19 Trade Date: 8/24 Shares: 7 million Underwriter(s) Credit Suisse[…]

Secondaries announced 08.22.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Sophiris Bio, Inc. Symbol: SPHS Price: Last trade $5.82 Description: No re-offer range available Trade Date: 8/23 Shares: 4.3 million Underwriter(s)[…]

Secondaries announced 8.18.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Jones Energy, Inc. Symbol: JONE Price: Last trade $3.58 Trade Date: 8/19 Shares: 14 million Underwriter(s) Credit Suisse, J.P. Morgan Rating=Subscription[…]

Secondaries announced 8.17.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Eiger BioPharmaceuticals, Inc. Symbol: EIGR Price: Last trade $17.19 Description: Re-offer range $16.00-$16.50 Trade Date: 8/18 Shares: 1.16 million Underwriter(s) JefferiesCo[…]

Scroll to top
error: Content is protected !!